Mojtaba Taheri's research while affiliated with Tarbiat Modares University and other places
What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
Publications (4)
Targeting actionable mutations in oncogene‐driven cancers and the evolution of immuno‐oncology are the two prominent revolutions that have influenced cancer treatment paradigms and caused the emergence of precision oncology. However, intertumoral and intratumoral heterogeneity are the main challenges in both fields of precision cancer treatment. In...
Citations
... Notwithstanding, several strategies are currently being developed to use MSCs as anti-cancer cell therapeutics. These include bioengineering MSCs to enhance their tumour homing and anti-tumour properties, or to carry as a "Trojan horse" some therapeutic agents that target and eliminate cancer cells more efficiently [24][25][26][27][28]. The development of such strategies requires a deep understanding of the interactions between MSCs, tumour microenvironment and immune system and calls for an interdisciplinary approach combining insights from cell biology, oncology and cell bioengineering to overcome current challenges and fully exploit the therapeutic potential of MSCs in cancer treatment. ...
![[object Object]](https://i1.rgstatic.net/ii/profile.image/857436231593984-1581440136221_Q64/Sadegh-Dehghani-4.jpg)
![[object Object]](https://i1.rgstatic.net/ii/profile.image/1043242590146561-1625739824542_Q64/Mona-Alibolandi.jpg)
![[object Object]](https://i1.rgstatic.net/ii/profile.image/539813785079808-1505713043590_Q64/Mohammad-Ramezani-14.jpg)
